Our results definitively show that GLUT3 siRNA-transfected shHDAC2-expressing GBM cells significantly increased PARP cleavage and Bax compared with DOX-inducible control GBM cells or DOX-untreated shHDAC2 GBM cells. This evidence concerns the gene SLC2A3 and glioblastoma.